Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
about
Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicityGenetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathwaysThe Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsLW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceNeuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialEarly intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's diseaseTargeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.Cognitive dysfunction with aging and the role of inflammationTriggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegenerationNuanced roles of cytokines in three major human brain disorders.Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized TrailElevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.Advanced BrainAGE in older adults with type 2 diabetes mellitus.Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction.Perispinal etanercept: a new therapeutic paradigm in neurology.Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity.Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathwaysPerispinal Delivery of CNS Drugs.Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.Immediate neurological recovery following perispinal etanercept years after brain injury.Is there a causal link between inflammation and dementia?Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.Brain abscesses complicating acute pneumococcal meningitis during etanercept therapy.Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.Subsyndromal delirium and its determinants in elderly patients hospitalized for acute medical illness.Curcumin requires tumor necrosis factor α signaling to alleviate cognitive impairment elicited by lipopolysaccharide.
P2860
Q21284512-31171AF8-8381-4124-91B7-E5D80F42CB9DQ24629875-846C8A6A-E41F-467B-A8A6-F9AD136A8FB0Q26783012-46D03D86-9D51-4C93-9A17-D30E594BA16CQ30831806-E54C3407-E75C-4D2B-A00E-BF8E25C7FD49Q33417987-1F5EEA2B-7A14-408A-B869-9C1D01866599Q33675845-5B9932AA-613B-43BE-AF6B-8C0C0C489DA9Q33947639-C54BBB67-9AA2-4854-A781-219FF7C1EFD1Q35116500-82ADDF1D-1E82-4B69-AA9F-05FBA182F48EQ35671005-81D3FEA2-6E2D-4B5F-891A-845D9D973CBBQ36112435-F847D607-1BC0-4163-BB5E-C302F040F487Q36330960-AA1C193A-C32F-47E7-842C-38DBA82694CCQ36443732-65C449F8-7474-49CD-8FF8-A4415313AE60Q36711812-37D21302-3C51-40A8-8CF3-02BDD0C03720Q36955568-E7D196DA-3E52-4FF9-864F-C54DBB070168Q37029990-758272FE-FA13-4FC7-8408-DC78DB85007AQ37061521-87D43816-4975-410A-84BB-54D97BFE0F4CQ37124980-CE217ABB-4410-4030-AE94-90ABD962785BQ37397736-D0F40237-1DC4-47E1-A184-3725E795F46BQ37680121-5F56E59F-9F38-4429-B279-3E0AAFEA53BDQ37762260-69DA732A-0E8E-4259-9F90-407F48613674Q37897498-1A0AC42B-EF44-4971-8BF0-B76A2A64B5B7Q38148183-285C4CB1-809F-4904-B2B3-3AAAC08B93E8Q38381041-E37F09EA-C507-413D-9619-3C39D239482CQ38819013-2A3C5C88-D7F0-49C4-8726-2DDD4A393897Q39023028-34685A4C-F36B-4394-AAA7-BF583C6984A8Q39209875-B9940184-1C2B-4F18-9957-4F827017A545Q39387457-FEEEF5BC-0BA8-4AA0-93E9-3CD1A517DA96Q39689655-5BE65B88-683D-4D1D-9899-801F50ACBF5BQ41279114-BB33CF20-E0FB-4F72-AEDB-CBC0FF2BF1D9Q42674268-893F6B95-8306-44B9-B714-722E1C8CFC7EQ43041358-0E19CF78-50D3-4116-8B2E-D71944BC4251Q45972237-0FB68488-05E1-440A-916C-7144862D76F9Q46473889-1EDF4012-5177-4341-AD8F-31E225C388E4Q46621101-440522BF-15A8-45DD-B3DE-0EB1C407DA7BQ50955136-8B0F3866-C0E9-4A01-866D-E1405F7B9DC0
P2860
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Rapid improvement in verbal fl ...... nercept in Alzheimer's disease
@nl
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@ast
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en-gb
type
label
Rapid improvement in verbal fl ...... nercept in Alzheimer's disease
@nl
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@ast
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en-gb
prefLabel
Rapid improvement in verbal fl ...... nercept in Alzheimer's disease
@nl
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@ast
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en-gb
P2860
P3181
P356
P1433
P1476
Rapid improvement in verbal fl ...... ercept in Alzheimer's disease.
@en
P2093
Edward L Tobinick
Hyman Gross
P2860
P2888
P3181
P356
10.1186/1471-2377-8-27
P407
P577
2008-07-21T00:00:00Z
P5875
P6179
1022045805